1
One Sample
A simple at-home finger-prick collected over 5 days. No clinic visits, no fasting, friction-free scaling.
Investor Relations
Building the infrastructure for preventive medicine.
We turn a single finger-prick into a continuously learning virtual twin. A dual-engine model: TwinMe monetizes non-medical wellness today, while BioTwin builds regulated clinical AI for cancer screening decision assistance and future disease detection pathways.
- Clinical pilot, Cleveland Clinic Abu Dhabi
- Microsoft for Startups
- $5M raised
Our Core Asset
Your Bio-Signature. 30,000+ biomarker-derived metabolic signals.
Your Bio-Signature. 30,000+ biomarker-derived metabolic signals.
Human virtual twin.
Standard lab panels quantify selected analytes. BioTwin maps 30,000+ biomarker-derived metabolic signals from a Bio-Signature sample using mass spectrometry, creating a high-dimensional dataset for proprietary AI. This is not equivalent to standard lab work.
2
30,000 Signals
High-resolution mass spectrometry captures a complete metabolic Bio-Signature, not just a targeted checklist.
3
3 Programs
Raw data is organized into actionable health programs: Healthspan and Longevity, Elite Health Optimization, and Weight Management.
4
Virtual Twin
A living mathematical model that learns retroactively. When our research team adds a new analysis, the twin updates without a new kit.
Go-to-market strategy
Consumer today.
Consumer today.
Clinical tomorrow.
The data required to train clinical AI for complex diseases is vast and expensive to acquire. BioTwin solves this cold-start problem through a self-funding data flywheel.
-
TwinMe (Consumer): We deliver immediate value through 3 commercial wellness programmes (Longevity, Elite Optimization, Weight) generating immediate revenue.
-
BioTwin (Clinical): Every anonymized finger-prick continuously expands our multi-omics database, directly training our predictive models for oncology and chronic diseases.
N=1
Personalized
Medicine
Medicine
"By mapping individual trajectories rather than population averages, we can detect minute biological deviations before they manifest as clinical symptoms."
Scientific Pipeline
Active clinical traction.
Our virtual twin technology is already deployed in real-world clinical environments.
Clinical pilot, active
Abu Dhabi, UAE Cleveland Clinic Abu Dhabi
BioTwin's first clinical pilot delivers results today through partner physicians at Cleveland Clinic Abu Dhabi. The programme is under the regulatory framework of the United Arab Emirates.
Current screening: Breast cancer · Colorectal cancer
Performance: Current models demonstrate 0.78 sensitivity across 6 cancer types using multi-omics integration.
Research in progress
Global Broader clinical pipeline
Beyond the UAE pilot, BioTwin runs active research programs globally, supported by over 50 published studies validating our biomarker Bio-Signatures.
- Oncology: Lung, Pancreas, Prostate, Ovarian
- Neurology: Alzheimer's, Parkinson's, Depression
- Cardiology: Heart failure, Hypertension
These are scientific projects, and TwinMe kit data contributes directly to them.
They believe in virtual twins
Dassault Systemes 
NVIDIA 
Twin Health Join our mission
We are building the definitive biological dataset for preventive medicine. To access our data room, clinical results, or speak with leadership, reach out today.
Contact Investor Relations